Skip to main content
. 2021 Dec 4;22(23):13126. doi: 10.3390/ijms222313126

Table 1.

snoRNAs with altered expression in ccRCC tumors when compared with controls.

snoRNA Alteration of Expression; Correlation with Prognosis (If Known) Ref.
NHG9, SNHG10, DANCR and SNHG14 Downregulated [45]
SNORA70F, SNORA2, SNORD116-24, SNORD116-4, SNORD116-2, SNORD116-26, SNORD116-1, SNORD116-27, SNORA80B Downregulated [45]
SNHG1, GAS5, SNHG3-8, SNHG11, SNHG12, SNHG15-17, SNHG20, SNHG22 and SNHG25 Upregulated; SNHG3: poor; SNHG15: poor [45]
SNORD63 and SNORD96A Upregulated [60]
SNORD99, SNORD60, SNORD104, SNORA73B, SNORD123, SNORD63, SNORA16, SNORA71A, SNORD93, SNORA71C, SNORA7, SNORD124, SNORD12B, SNORD117, SNORA53, SNORA59B, snoZ196, SNORD17, SNORD15B Upregulated; poor (for the signature consisting of six snoRNAs (six of them (SNORA2, SNORD12B, SNORA59B, SNORA70B, SNORD93 and SNORD116-2) [46]
SNHG1 Upregulated; poor [51]
SNHG4 Upregulated; poor [54]
SNHG6 Upregulated; poor [58]
SNHG12 Upregulated; poor [47,48,49,50]